Tissue engineering of bladder using vascular endothelial growth factor gene-modified endothelial progenitor cells

International Journal of Artificial Organs

Volumn 34, Issue 12, 2011, Pages 1137-1146

  Chen, Bai Song ^a   Xie, Hua ^a   Zhang, Sheng Li ^a   Geng, Hong Quan ^b   Zhou, Jun Mei ^a   Pan, Jun ^b   Chen, Fang ^a  

^a SHANGHAI CHILDREN S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Bladder; Endothelial progenitor cells (EPCs); Gene therapy; Tissue engineering; Vascular endothelial growth factor (VEGF)

Indexed keywords

BLOOD; CELL ENGINEERING; CYTOLOGY; ENDOTHELIAL CELLS; MAMMALS; POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; TISSUE; TISSUE ENGINEERING;

ACELLULAR MATRIX GRAFTS; BLADDER; CELL-BE; CELL/B.E; CELL/BE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIAL PROGENITOR CELLS; TISSUES ENGINEERINGS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

GENE THERAPY;

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BLADDER; BLADDER ACELLULAR MATRIX GRAFT; BLADDER REGENERATION; CELL ADHESION; CELL EXPANSION; CELL ISOLATION; CELL PROLIFERATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYSTECTOMY; DENSITY; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MICROVESSEL DENSITY; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING; TISSUE GRAFT; TISSUE REGENERATION; TRICHOME; VASCULARIZATION;

EID: 84455181390     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000069     Document Type: Article

References (27)

1. Mingin GC, Stock JA, Hanna MK. Gastrocystoplasty: longterm complications in 22 patients. J Urol. 1999;162:1122. Medline. doi:10.1016/S0022-5347(01)68092-3
2. Kronner KM, Casale AJ, Cain MP, Zerin MJ, Keating MA, Rink RC. Bladder calculi in the pediatric augmented bladder. J Urol. 1998;160:1096. Medline. doi:10.1016/S0022-5347(01)62707-1
3. Atala A. Tissue engineering of human bladder. Br Med Bull. 2011;97(1):81-104. Medline. doi:10.1093/bmb/ldr003
4. Brown AL, Farhat W, Merguerian PA, Wilson GJ, Khoury AE, Woodhouse KA. 22 week assessment of bladder acellular matrix as a bladder augmentation material in a porcine model. Biomaterials. 2002;23:2179. Medline. doi:10.1016/ S0142-9612(01)00350-7
5. Kanematsu A, Yamamoto S, Noguchi T, Ozeki M, Tabata Y, Ogawa O. Bladder regeneration by bladder acellular matrix combined with sustained release of exogenous growth factor. J Urol. 2003;170:1633. Medline. doi:10.1097/01. ju.0000084021.51099.8a
6. Pike DB, Cai S, Pomraning KR, et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials. 2006;27:5242. Medline. doi:10.1016/j. biomaterials.2006.05.018
7. Nillesen ST, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, van Kuppevelt TH. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials. 2007;28:1123. Medline. doi:10.1016/j.biomaterials.2006.10.029
8. Peters MC, Polverini PJ, Mooney DJ. Engineering vascular networks in porous polymer matrices. J Biomed Mater Res. 2002;60:668. Medline. doi:10.1002/jbm.10134
9. Murohara T, Ikeda H, Duan J, et al. Transplanted cord bloodderived endothelial precursor cells augment postnatal neovascularization. J Clin Invest. 2000;105:1527. Medline. doi:10.1172/JCI8296
10. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000;97:3422. Medline. doi:10.1073/pnas.070046397
11. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells utilizing human peripheral and umbilical cord blood. Blood. 2004;104:2752. Medline. doi:10.1182/blood-2004-04-1396
12. Chen F, Yoo JJ, Atala A. Acellular collagen matrix as a possible "off the shelf" biomaterial for urethral repair. Urology. 1999;54:407. Medline. doi:10.1016/S0090-4295(99)00179-X
13. Atala A. Tissue engineering in urologic surgery. Urol Clin North Am. 1998;25:39. Medline. doi:10.1016/S0094- 0143(05)70431-6
14. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 2006;367:1241. Medline. doi:10.1016/S0140- 6736(06)68438-9
15. Rivron NC, Liu JJ, Rouwkema J, de Boer J, van Blitterswijk CA. Engineering vascularised tissues in vitro. Eur Cell Mater. 2008;15:27-40. Medline.
16. Rouwkema J, Rivron NC, van Blitterswijk CA. Vascularization in tissue engineering. Trends Biotechnol. 2008;26(8):434-441. Medline. doi:10.1016/j.tibtech.2008.04.009
17. Guan Y, Ou L, Hu G, et al. Tissue engineering of urethra using human vascular endothelial growth factor gene-modified bladder urothelial cells. Artif Organs. 2008;32(2):91-99. Medline. doi:10.1111/j.1525-1594.2007.00502.x
18. De Coppi P, Delo D, Farrugia L, et al. Angiogenic genemodified muscle cells for enhancement of tissue formation. Tissue Eng. 2005;11(7-8):1034-1044. Medline. doi:10.1089/ ten.2005.11.1034
19. Delo DM, Eberli D, Williams JK, Andersson KE, Atala A, Soker S. Angiogenic gene modification of skeletal muscle cells to compensate for ageing-induced decline in bioengineered functional muscle tissue. BJU Int. 2008;102(7):878-884. Medline. doi:10.1111/j.1464-410X.2008.07750.x
20. Yoo JJ, Meng J, Oberpenning F, Atala A. Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology. 1998;51:221. Medline. doi:10.1016/S0090- 4295(97)00644-4
21. Goh PP, Sze DM, Roufogalis BD. Molecular and cellular regulators of cancer angiogenesis. Curr Cancer Drug Targets. 2007;7:743. Medline. doi:10.2174/156800907783220462
22. Wu S, Wang Z, Bharadwaj S, Hodges SJ, Atala A, Zhang Y. Implantation of autologous urine derived stem cells expressing vascular endothelial growth factor for potential use in genitourinary reconstruction. J Urol. 2011;186(2):640-647. Medline. doi:10.1016/j.juro.2011.03.152
23. Roncalli JG, Tongers J, Renault MA, Losordo DW. Endothelial progenitor cells in regenerative medicine and cancer: a decade of research. Trends Biotechnol. 2008;26:276. Medline. doi:10.1016/j.tibtech.2008.01.005
24. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004;95:343. Medline. doi:10.1161/01.RES.0000137877.89448.78
25. Kawamoto A, Tkebuchava T, Yamaguchi J, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation. 2003;107:461. Medline. doi:10.1161/01. CIR.0000046450.89986.50
26. Schächinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE- AMI Trial. J Am Coll Cardiol. 2004;44:1690. Medline.
27. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407:242. Medline. doi:10.1038/35025215